NOVOMEDIX

We are a biotechnology company developing novel small molecule multi-pathway modulators for the treatment of cancer, fibrosis, and inflammatory diseases. We have amassed a significant wealth of expertise in our therapeutic areas of interest, with decades of drug development experience... Our Management, Board of Directors, and Scientific Advisory Board are comprised of world-class drug development experts with proven expertise in cancer and fibrosis. Our team shares a collective vision to improve the treatment paradigm in these disease areas by developing better therapies.

Also known as: NovoMedix, LLC